NCT01059812 A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01059799 Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01053234 Different Insulin Regimens and Postprandial Coagulation Activation Status COMPLETED Phase NA
NCT01046110 Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin Status COMPLETED Phase PHASE3
NCT01045707 Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01045447 Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01044108 A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers Status TERMINATED Phase PHASE1
NCT01043510 The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin Status COMPLETED Phase PHASE1
NCT01038674 Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01037582 A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01034202 Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® Status COMPLETED Phase PHASE1
NCT01030926 A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01028404 A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01024218 Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle Status COMPLETED Phase PHASE4
NCT01022762 Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment Status COMPLETED Phase PHASE4
NCT01018238 An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) Status WITHDRAWN Phase PHASE1
NCT01009905 An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone) Status COMPLETED Phase N/A
NCT01009580 Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01006291 Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes Status COMPLETED Phase PHASE3